Infographic: five-year outcomes after initial aflibercept, bevacizumab, or ranibizumab treatment for diabetic macular edema (DRCR Protocol T Extension Study)

Eye 2026

View at publisher

Authors: Eleonora Riotto, Francesca Lamanna, Venughanan Manikavasagar, Livia Faes, Dun Jack Fu

DOI: 10.1038/s41433-026-04321-7

Cited by: 0

Fields of Study & Subjects

Retinal Diseases and Treatments Retinal and Macular Surgery Ocular Diseases and Behçet’s Syndrome